UroGen Pharma Ltd (URGN) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist

9.460
+0.170+1.83%

Close Feb 28 16:00 ET

9.460
0.0000.00%

Post 20:01 ET

399.21MMarket Cap-3.13P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Press Release: UroGen Pharma to Report Fourth Quarter and Full-Year 2024 Financial Results on Monday, March 10, 2025
Dow JonesFeb 27 08:05 ET
When Can We Expect A Profit From UroGen Pharma Ltd. (NASDAQ:URGN)?
Simply Wall StFeb 27 06:05 ET
UroGen Pharma to Report Fourth Quarter and Full-Year 2024 Financial Results on Monday, March 10, 2025
UroGen PharmaFeb 27 00:00 ET
Is UroGen Pharma Ltd. (URGN) the Best Small-Cap Growth Stock to Buy Now?
Yahoo FinanceFeb 25 12:30 ET
H.C. Wainwright Maintains UroGen Pharma Ltd(URGN.US) With Buy Rating, Maintains Target Price $64
Moomoo NewsFeb 25 07:33 ET · Ratings
UroGen Pharma to Present at TD Cowen 45th Annual Health Care Conference
UroGen PharmaFeb 24 00:00 ET

Comments

Teddy123

Feb 20 07:16

UroGen Advances Long-Term Growth Strategy by Acquiring a Next-Generation Investigational Oncolytic Virus (ICVB-1042) and Announces Multiple Strategic Research Collaborations

$UroGen Pharma Ltd (URGN.US)$
UroGen's Major Pipeline Play: Revolutionary Cancer-Fighting Virus Acquisition Reshapes Growth Strategy

Airbags

Feb 17 23:38

💪

$UroGen Pharma Ltd (URGN.US)$

Teddy123

Feb 14 13:54

UroGen Announces Results from Subgroup Analyses of the Pivotal ENVISION Trial Evaluating Impact of Baseline Tumor Burden and Focality on Response to UGN-102

$UroGen Pharma Ltd (URGN.US)$
Breakthrough Bladder Cancer Treatment Achieves 83% Response Rate, FDA Decision Coming 2025

Teddy123

Feb 12 07:23

Data from a Long-Term Follow-up Study to the OLYMPUS Trial that Shows a Median Duration of Response of Nearly Four Years in Patients Achieving Complete Response with JELMYTO Published in The Journal o

$UroGen Pharma Ltd (URGN.US)$
Clinical Trial Results: Cancer Drug Maintains Response for Nearly 4 Years, Surpassing Expectations

Stock_Drift

Oct 15, 2024 15:37

$UroGen Pharma Ltd (URGN.US)$

Trending Stocks

Symbol Mini Chart % Chg

Halozyme Therapeutics

HALO

+2.51%

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

DMZPY

+2.27%

Collegium Pharmaceutical

COLL

+2.22%

Unlock the Full List